Safety of fetal blood sampling by cordocentesis in fetuses with single umbilical arteries

Prenat Diagn. 2004 Aug;24(8):605-8. doi: 10.1002/pd.920.

Abstract

Objectives: To examine the safety of cordocentesis in fetuses with single umbilical arteries.

Methods: Retrospective analysis of all cases of cordocenteses in fetuses with single umbilical arteries over a five-year period at one centre. We analysed the records for pregnancy details, outcomes, and procedure-related complications, and compared these to similar data for cordocenteses procedures performed, during the same period, for similar indications in fetuses with three-vessel cords.

Results: Twenty-nine eligible cases were identified. All procedures were performed for the indication of fetal structural abnormalities, and seven fetuses (24%) had abnormal karyotypes. The median gestational age at the time of the procedure was 21 weeks (range 19-34 weeks). There were no procedure-related fetal losses but the umbilical artery was inadvertently punctured in one case, resulting in prolonged bradycardia with spontaneous recovery. These outcomes compare favourably to those of a total of 134 cordocenteses procedures in fetuses with three-vessel cords.

Conclusion: Cordocentesis in cases with single umbilical arteries does not appear to carry more risk than in cases with three-vessel cord, and should continue to be performed by adequately trained specialists when indicated. Extra care should be undertaken to avoid puncturing the umbilical artery.

MeSH terms

  • Chromosome Aberrations
  • Cordocentesis / adverse effects*
  • Female
  • Fetal Blood / chemistry*
  • Gestational Age
  • Humans
  • Karyotyping
  • Pregnancy
  • Pregnancy Outcome
  • Retrospective Studies
  • Risk Factors
  • Ultrasonography, Prenatal
  • Umbilical Arteries / abnormalities*
  • Umbilical Arteries / injuries